According to a recently published SEC filing, Square Inc Director Vinod Khosla has stepped down from the company’s board of directors ahead of its initial public offering (IPO).
The company said that Khosla had previously expressed his desire to step down from the position, consistent with his stated preference not to serve on the boards of directors of public companies. He will remain an advisor to the board.
He served as a member of Square’s board of directors since June 2011. Since April 2004, he has served as a General Partner of Khosla Ventures, a venture capital firm. Prior to that, Khosla served as a General Partner of Kleiner Perkins Caufield & Byers, a venture capital firm, and as Chief Executive Officer of Sun Microsystems, Inc.
The mobile payment company, led by Twitter Inc Chief Executive Jack Dorsey, filed for an IPO on Oct. 14, offering around $275 million in stock.
Square also reported a 49 percent jump in net revenue to $892.8 million for the nine months ended Sept. 30, while net loss widened to $131.5 million, or 88 cents per share, from $117.0 million, or 84 cents per share, a year earlier, Reuters reported.


OpenAI Seeks $30 Billion at $1.4 Trillion Valuation
Pi Network Price Holds $0.087 as Protocol 28 Mainnet Upgrade Nears
Robinhood Launches AI Agents for Automated Trading
Samsung Invests $1 Billion in KKR’s Helix AI Infrastructure
Apple iPhone 18 Pro Sales Jump 12% in China
Google Pays Publishers for AI Search Content in New Pilot
Amazon Eyes $8 Billion Nvidia Chip Spinoff to Fund AI Expansion
WordPress Malware Uses Ethereum to Evade Removal
Trump, Tech Leaders Sign ‘Morally Binding’ AI Safety Accord
Morgan Stanley Raises TD Synnex Price Target to $359 on Strong AI Demand
AI Agents Could Disrupt Financial Services, Bernstein Says
DogeOS Launches Testnet to Bring DeFi Apps to Dogecoin
Vitalik Buterin Says Hegota Could Be Ethereum’s Last Conventional Fork
DeepSeek, Huawei Partner on Ascend AI Chip Programming Tools
BlackRock Sees AI Agents Fueling New Crypto Demand
Polymarket Traders Bet on Trump AI Rename to ‘Super Intelligence’
CSL Partners With AWS to Bring AI Into Drug Research 



